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To assess whether the expression of connexins (Cx) by
keratinocytes is altered under conditions of abnormal
epidermal differentiation, we have compared Cx26, Cx32,
Cx37, Cx40, and Cx43 in the epidermis of 11 psoriatic
patients who had not been treated for at least 1 mo and
of seven healthy individuals. In all samples of fully mature
psoriatic plaques, we have observed a massive expression
of Cx26, as judged at both the transcript level (northern
blot) and the protein level (immunofluorescence). This
protein became consistently detected between ker-
atinocytes of the basal and granular layers at the periphery
of psoriatic plaques and in all layers of fully developed
psoriatic epidermis, except in regions of parakeratosis.
None or a minimal amount of Cx26 was observed in both
control and nonlesional regions of psoriatic epidermis.
Human keratinocytes share ions (Van Heulekom et al,1972), small metabolites (Hunter and Pitts, 1981), andlow molecular weight tracers (Salomon et al, 1988)through intercellular channels, located at gap junctions.These channels are made of transmembrane proteins
called connexins (Cx), which in mammals form a family of 13 members
(Bruzzone et al, 1996; Kumar and Gilula, 1996). The gap junctions of
human keratinocytes comprise at least two distinct connexins, referred
to as Cx43 and Cx26. Cx43 has been found to be abundantly expressed
throughout the interfollicular epidermis (Guo et al, 1992; Salomon
et al, 1994) and in some epidermal adnexae (Salomon et al, 1994),
whereas Cx26 has been found to be restricted to the latter structures
(Salomon et al, 1994). Three others connexins (Cx32, Cx37, Cx40),
which have not been detected in keratinocytes of normal human skin
(Salomon et al, 1994), were also tested as an internal negative control.
Even though the role of gap junctions in epidermal homeostasis
remains to be demonstrated, it has been proposed that gap junction-
mediated communication is involved in the regulation of keratinocyte
growth and differentiation (Pitts et al, 1988; Salomon et al, 1993;
Brissette et al, 1994; Goliger and Paul, 1995). Thus, the differential
distribution of Cx43 and Cx26 within interfollicular epidermis and
epidermal adnexae may be related to the specific differentiation program
that keratinocytes undergo in various skin regions. Consistent with this
view is the recent finding that alterations in keratinocyte differentiation
induced by a chronic treatment with retinoic acid are associated
with a marked increase in the expression of Cx26 within human
interfollicular epidermis (Masgrau-Peya et al, 1997).
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Psoriatic plaques also contained Cx43, the prominent
gap junction protein in the interfollicular epidermis of
normal human skin. The levels of this protein appeared
to be slightly higher in psoriatic than in control skin, as
judged at both the transcript level (northern blot) and
the protein level (immunofluorescence). Three other
connexins (Cx32, Cx37, and Cx40), which are not
observed in control interfollicular epidermis, were not
induced in either nonlesional or lesional regions of psori-
atic skin. The data indicate that selective changes in the
normal expression of connexins by keratinocytes are
associated with the changes in the proliferation and
differentiation program that these cells undergo in psori-
asis. Key words: gap junctions/psoriasis. J Invest Dermatol
111:72–76, 1998
To assess whether connexin expression is also modified when the
differentiation program of keratinocytes is altered as part of a pathologic
process, we have now studied gap junction proteins in the epidermis
of patients affected by psoriasis. Even though the etiology of this
disease remains a matter of debate, the morphologic and biochemical
alterations of interfollicular keratinocytes that take place in psoriatic
epidermis are well characterized (Mc Kay and Leigh, 1995). Included
in these alterations is an increase in the number of gap junctions
observed by freeze-fracture electron microscopy (Caputo et al, 1978),
which suggests that altered gap junctional communication somehow
contributes to, or is a consequence of, the abnormal differentiation
program of psoriatic keratinocytes. Here, we show that psoriatic
keratinocytes massively express Cx26, a connexin that is not expressed
by normal human interfollicular epidermis, in addition to native Cx43,
the prominent gap junction protein of this tissue in normal human skin.
MATERIALS AND METHODS
Patients Eleven psoriatic patients, who had given informed consent, were
studied in accordance with the guidelines of our institutional committee for
clinical investigation. All patients had chronic and stable psoriatic plaques and
had not been treated by systemic drugs or phototherapy in the month preceding
sampling. During this period, the skin area that was to be sampled was also not
treated by any topical drug. The sex ratio of these patients was 1.8 men/women
and the mean age was 38.5 y (range 21–59 y).
Tissue sampling For both immunofluorescence and northern blot analysis,
buttock skin was anesthetized by an intradermal injection of 1% xylocaine plus
epinephrine and regions of lesional and nonlesional skin were separately sampled
in five patients. In the six other patients, biopsies were performed at the border
of psoriatic plaques, in order to obtain samples comprising both lesional and
nonlesional areas. In the case of psoriatic plaques, samples were obtained using
a dermatome set at 1.2 mm thickness, whereas for normal skin the dermatome
thickness was set at 0.3–0.4 mm, so as to obtain the entire epidermis
with minimal contamination of dermis. To assess whether this unavoidable
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contamination influenced the connexin changes observed at the transcript level,
northern blot analysis were also extended to samples of thermolysin split
epidermis from control skin (Salomon et al, 1994). All samples were rapidly
frozen by immersion in 2-methylbutane (Merck, ABS, Basel, Switzerland),
which was cooled in liquid nitrogen and stored at –80°C until cryostat sectioning.
Immunostaining Sections of 5 mm thickness were cut with a cryomicrotome
(1720 digital MGW Leitz, Germany), collected on gelatin-coated slides, and
fixed for 3 min in –80°C acetone. All slides were then rinsed in cold (4°C)
phosphate buffered-saline containing 0.5% bovine serum albumin and processed
for indirect immunofluorescence.
For localization of gap junction proteins, sections were first incubated for
2 h at room temperature with one of the following antibodies: (i) affinity-purified
rabbit polyclonal antibodies against liver Cx32, diluted 1:100 (Dermietzel et al,
1984); (ii) affinity-purified rabbit polyclonal antibodies against residues 108–
122 of liver Cx26, diluted 1:500 (Goliger and Paul, 1994); (iii) mouse
monoclonal antibodies against a segment of the cytoplasmic loop of Cx26,
diluted 1:200 (Zymed Laboratory, San Francisco, CA); (iv) affinity-purified
rabbit polyclonal antibodies against the carboxy-terminal portion of mouse liver
Cx26, diluted 1:100 (Traub et al, 1989); (v) affinity-purified rabbit polyclonal
antibodies against residues 314–322 of heart Cx43, diluted 1:100 (Salomon
et al, 1994); (vi) mouse monoclonal antibodies against 19 amino acids of the
carboxy terminal portion of Cx43, diluted 1:500 (Zymed Laboratory); (vii)
affinity-purified rabbit polyclonal antibodies against residues 313–330 of Cx40,
diluted 1:100 (Bruzzone et al, 1993); (viii) affinity purified rabbit polyclonal
antibodies against residues 266–281 of Cx37, diluted 1:200 (Haefliger et al,
unpublished, Haefliger School of Medicine, University of Lausanne, Switzer-
land). Sections were rinsed in phosphate-buffered saline and incubated for 1 h at
room temperature with fluorescein-conjugated anti-rat or anti-rabbit antibodies,
whichever applicable, diluted 1:200. After further rinsing, sections were stained
with a 0.03% Evans’ blue solution, covered with 0.02% paraphenylenediamine
in phosphate-buffered saline-glycerol (1:2, vol:vol), and photographed with an
Axioplan microscope (Zeiss, Oberkochen, West Germany) fitted with filters
for fluorescein detection.
In all experiments, negative controls included exposure of sections during
the first incubation to either one of the following reagents: preimmune serum,
normal rabbit or mouse serum, fluorescein-conjugated anti-rabbit or anti-mouse
antibodies. Cryosections of rat liver, pancreas, and heart, as well as of mouse
skin, were incubated in parallel with the human samples and used as positive
controls for the different antibodies tested.
Plasmid constructions cDNA coding for human connexins were kindly
provided by Drs. G.I. Fishman (Cardiovascular Institute, New York, NY) and
R. Sager (Dana Faber Cancer Institute, Boston, MA). These cDNA that
contained the entire coding region of Cx43 (Fishman et al, 1990) and Cx26
(Lee et al, 1992) were subcloned in plasmid Bluescript II KS and linearized
with Xho I and EcoR I (for Cx43) and Hind III and EcoR I (for Cx26)
restriction site enzymes (Boehringer, Mannheim, Germany), as described in
Salomon et al (1994). Connexin anti-sense probes were synthesized by in vitro
transcription (Meda et al, 1993). Previous studies have shown that the probes
for these two connexins have no cross-reactivity when tested on total RNA
extracted from human skin (Salomon et al, 1994).
Identification of connexin transcripts Skin samples were homogenized in
2.5 ml 0.1 M Tris-HCl, pH 7.4, containing 1.3 M b-mercaptoethanol and 4 M
guanidium thiocyanate. After addition of solid CsCl (0.4 g per ml), the
homogenate was layered on a 2 ml cushion of 5.7 M CsCl–0.1 M ethylenediam-
ine tetraacetic acid (pH 7.4) and centrifuged for 20 h at 35,000 r.p.m. and 20°C.
Pelleted RNA was resuspended in 10 mM Tris-HCl, pH 8.1, supplemented with
5 mM ethylenediamine tetraacetic acid and 0.1% sodium dodecyl sulfate,
extracted twice with phenol-chloroform, precipitated in ethanol, and resus-
pended in water. For northern blots, total cellular RNA was denatured with
1 M glyoxal in 0.01 M phosphate buffer containing 50% dimethylsulfoxide,
electrophoresed in a 1% agarose gel (5–10 mg total cellular RNA per lane),
and transferred overnight onto nylon membranes (Hybond N; Amersham
International). Filters were exposed for 30 s to 302 nm light and stained with
methylene blue. Filters were prehybridized at 2 h and 65°C in a 0.05 M Pipes-
buffered (pH 6.8) solution of 50% formamide, which was supplemented with
2 mM ethylenediamine tetraacetic acid, 0.1% sodium dodecyl sulfate, 0.1 mg
salmon sperm DNA per ml, 0.8 M NaCl, and 2.53Denhardt’s solution. Filters
were then hybridized for 18 h at 65°C with 23106 cpm solution 32P-labeled
probe per ml, washed twice at 65°C in 33SSC and 23Denhardt’s solution,
followed by three washings at 70°C in 0.23SSC, 0.1% sodium dodecyl sulfate,
and 0.1% sodium pyrophosphate. Filters were then exposed to XAR-5 film
(Eatsman Kodak, Rochester, NY) between intensifying screens at –80°C for
1–4 d.
RESULTS
Expression of Cx26 is highly upregulated in psoriatic
plaques Incubations of cryosections of psoriatic plaques with two
different anti-sera against Cx26 resulted in the decoration of ker-
atinocytes by numerous immunofluorescent spots (Figs 1, 2). This
immunolabeling was observed in all epidermal layers, except those
showing parakeratosis, and was detected in all the patients studied
(Figs 1, 2). Higher magnification views of the immunolabeled sections,
revealed that virtually all the Cx26 observed in psoriatic plaques was
located at discrete spots of the keratinocyte membrane, in areas of cell-
to-cell contact (Fig 2). In contrast, minimal levels of this protein
were immunodetected in the interfollicular epidermis of control and
nonlesional skin (Fig 2). These low levels escaped detection at low
magnification, under conditions that clearly showed intense labeling
of psoriatic skin (Fig 1). Using the same antibodies, Cx26 was also
readily detected in epidermal adnexae of normal skin (not shown).
Northern blot analysis showed that Cx26 mRNA was abundantly
expressed in psoriatic plaques of the 11 patients studied, whereas it was
not at a detectable level in samples of total control skin (Fig 3);
however, minimal amounts of the Cx26 transcript were detected in
preparations exclusively constituted by epidermis, which were obtained
after a thermolysin splitting of normal human skin (Fig 3).
Cx26 is differentially expressed throughout the epidermis of
psoriatic patients Immunostaining of nonlesional skin from patients
with psoriasis failed to detect Cx26 between keratinocytes of interfollic-
ular epidermis (Fig 1); however, Cx26 was readily detected in the
very same samples within hair follicles and ducts of sweat glands (not
shown). Biopsies involving both nonlesional and lesional regions,
revealed that Cx26 first became detectable between keratinocytes of
the basal and granular layers (Fig 1). As judged by the abundance of
the immunostaining, Cx26 expression appeared to progressively increase
throughout the spinous layers, and was clearly detectable in all
layers of viable keratinocytes within fully developed psoriatic plaques
(Figs 1, 2).
Northern blots of nonlesional skin of psoriatic patients also showed
detectable levels of Cx26 mRNA that were much lower, however,
than those found in fully developed psoriatic plaques (Fig 3).
Expression of Cx43 is slightly increased in psoriatic
plaques Immunostaining of cryosections using two different antibod-
ies, revealed that Cx43 was distributed in psoriatic plaques in a similar
manner to that in the interfollicular epidermis of control skin (Fig 4).
Thus, in both normal and psoriatic epidermis, Cx43 was weakly
immunodetected between the keratinocytes of the basal layer, was
abundant in those of middle and upper spinous layers, and disappeared
in those of stratum corneum, whether this layer was orthokeratotic
(normal epidermis) or parakeratotic (psoriatic epidermis). No difference
in Cx43 distribution was observed between nonlesional and lesional
regions of the epidermis in the 11 patients examined; however, as
judged by the abundance of immunofluorescent spots, Cx43 appeared
more abundant in psoriatic plaques than in control and nonlesional
epidermis (Fig 4). At higher magnification, it was clear that virtually
all the Cx43 detected by the different antibodies used was located at
discrete membrane domains (not shown).
Analysis of adnexae of lesional skin failed to detect changes in
Cx43 immunolabeling (not shown). Northern blot analysis showed
comparable levels of Cx43 mRNA in control and psoriatic epidermis
(Fig 3).
Three other connexins are not upregulated in psoriatic
epidermis Antibodies that identified Cx32, Cx37, and Cx40 in
control human tissues (liver for Cx32, heart for Cx37 and Cx40),
failed to detect these gap junction proteins in the interfollicular
epidermis and epidermal adnexae of both control and psoriatic skin
(not shown). These negative findings are in agreement with previous
reports on both human (Salomon et al, 1994) and rodent epidermis
(unpublished).
DISCUSSION
Human keratinocytes are connected by numerous gap junctions (Wolff
and Schreiner, 1968), which allow for direct cell-to-cell exchanges of
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Figure 1. Distribution of Cx26 in lesional and nonlesional psoriatic skin. (A) Phase-contrast view of a biopsy comprising a phenotypically normal region
of skin (left side of the photograph) and a region immediately adjacent to a psoriatic plaque (right side of the photograph). (B) Immunolabeling failed to reveal
Cx26 in normal interfollicular epidermis (left side of the photograph), but showed this gap junction protein in the basal, upper spinous, and granular layers of the
same tissue in the region surrounding a fully developed psoriatic plaque (right side of the photograph). (C) Phase-contrast view of the fully developed psoriatic
plaque that is shown in (D). (D) Within psoriatic plaques, Cx26 was detected throughout all living layers of keratinocytes, where it was expressed in much higher
levels than in the nonlesional and perilesional regions of the very same patients. In contrast, no Cx26 was detected in the keratinized and parakeratotic regions of
squamous layers. Scale bar: 100 µm.
Figure 2. Cx26 is expressed at the membrane of keratinocytes. High magnification analysis of the skin sections incubated with antibodies against Cx26,
revealed that this protein was clearly located at the membrane of the keratinocytes that formed the bulk of psoriatic plaques (A). Comparison with the situation in
normal skin (B) further revealed that the membrane spots immunostained for Cx26 were much more abundant in psoriatic plaques than in control interfollicular
epidermis. Scale bar: 25 µm.
Table I. Connexins 43 and 26 are upregulated between keratinocytes of psoriatic epidermisa
Psoriatic epidermis
Normal epidermis Nonlesional Border Lesional
Cx43 Cx26 Cx43 Cx26 Cx43 Cx26 Cx43 Cx26
Str. Basale 1 – 1 – 1 1 11 1
Str. Spinosum 111 – 111 – 111 – 1111 111
Str. Granulosum 11 1/– 11 1/– 111 111 111 111
Str. Corneum
orthokeratosis – – – – – – – –
parakeratosis n.o. n.o. n.o. n.o. n.o. n.o. – –
a1 and –, presence and absence, respectively, of immunolabeling of connexin 43 and connexin 26; 1/–, a weak inconsistent immunolabeling of connexin 43 and connexin 26; n.o.,
none observed
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Figure 3. Cx43 and Cx26 transcripts are differentially increased in
psoriatic epidermis. Upper panel: northern blot analysis of total RNA (5 µg
per lane) revealed the presence of a Cx26 mRNA in samples of both lesional
(L) and nonlesional (NL) psoriatic skin, but not in samples of total skin (TS)
obtained from healthy controls. In all psoriatic patients, the levels of this mRNA
were much larger in plaque regions showing the full complement of psoriatic
alterations (L) than in nearby, phenotypically normal regions of the skin (NL).
No Cx26 mRNA was detectable in samples of total control skin (TS). By
contrast, minute traces of Cx26 mRNA were barely detectable in samples of
epidermis that were prepared by enzymatic splitting (SE) of normal skin. Lower
panel: when the same RNA samples were tested for Cx43, a transcript encoding
this connexin was detected in all samples studied. No quantitative analysis of
this type of blot was performed in this study.
low molecular weight cytoplasmic molecules and ions (Pitts et al, 1988;
Salomon et al, 1993; Goodenough et al, 1996). In the interfollicular
epidermis of normal human skin, the predominant gap junction protein
is Cx43 (Guo et al, 1992; Salomon et al, 1994), a connexin that is
weakly expressed between the keratinocytes of the basal layer and
abruptly increases between those of suprabasal layers (Salomon et al,
1994). In the granular layers, Cx43 is coexpressed with minute amounts
of another gap junction protein, referred to as Cx26 (Kelsell et al,
1997), which is not detectable by immunolabeling elsewhere in the
human interfollicular epidermis (Guo et al, 1992; Wingelbus et al,
1992; Salomon et al, 1994; Rivas et al, 1997), but is abundant within
hair follicle and ducts of sweat glands (Salomon et al, 1994; Rivas et al,
1997). This differential distribution suggests that gap junctions and
the direct cell-to-cell communications that these structures permit,
contribute to the program of migration and acquisition of specific
structural and metabolic features that lead to full keratinocyte differenti-
ation. This contribution is further supported by the recent finding that
a chronic application of all-trans retinoic acid, a treatment that is
known to markedly modify the differentiation program of adult
epidermis (Rosenthal et al, 1992), is associated with changes in
connexins, including a modest increase in the expression of Cx43 and
a much more strikingly and large induction of Cx26 (Masgrau-Peya
et al, 1997). To assess whether connexin changes also take place during
pathologic alterations of human epidermis, we have studied psoriasis,
a skin disease characterized by major changes in the proliferation,
migration, differentiation, and shedding of keratinocytes (Mc Kay and
Leigh, 1995).
We have found that, compared with normal interfollicular epidermis,
the thickened and parakeratotic epidermis of psoriatic plaques featured
a modest increase in the levels of Cx43 and a massive induction of
Cx26, as judged at both the transcript and the protein levels. These
findings are consistent with the recent observation that the gene
encoding Cx26 is among the few that are markedly upregulated in
psoriatic epidermis (Rivas et al, 1997). This study further documents that
the increased expression of gap junction proteins occurred according to
a specific spatial pattern. Hence, even though Cx43 and Cx26 were
found increased throughout all living layers of the interfollicular
epidermis, this change predominated in the suprabasal layers. At the
light microscopic level, both Cx26 and Cx43 appeared to be mostly
expressed at the membrane of keratinocytes, consistent with previous
reports locating enlarged gap junction plaques on the membrane of
psoriatic keratinocytes (Caputo et al, 1978). Interestingly, no change
in either Cx26 or Cx43 was detected within epidermal adnexae, which
are little, if at all, involved in psoriasis. Furthermore, the induction of
Cx26 appeared less prominent at the border than in the center of
psoriatic plaques, and was not observed in the noninvolved regions
that displayed a histologically normal skin organization. In these regions,
the interfollicular epidermis of psoriatic patients contained Cx43 and
virtually no Cx26, like that of healthy controls. These findings indicate
that the upregulation of the Cx26 gene and protein expression parallels
the gradient of histologic and metabolic alterations that lead from a
noninvolved epidermis to the hyperplastic and abnormally differentiated
epidermis of fully mature psoriatic plaques. The observation of altered
expression of Cx26 in areas that did not yet feature all the histologic
alterations that characterize these fully mature plaques, further indicates
that the connexin changes are associated with the progression of
psoriatic alterations. Because many other biochemical changes also
show a gradient of expression between the noninvolved skin and the
fully developed plaques of psoriasis (Mc Kay and Leigh, 1995), further
studies are now required to determine which of these changes is
necessary, if not causal for the progression of psoriatic alterations.
The modest change in Cx43 and the massive induction of Cx26
observed here, are reminiscent of the connexin changes reported after
chronic application of retinoic acid on normal skin (Masgrau-Peya
et al, 1997). Under these conditions the thickness of interfollicular
epidermis was increased and keratinocytes were induced to express
keratin K6, a marker of increased proliferation (Rosenthal et al, 1992),
which is also observed in psoriasis (Stoler et al, 1988). Together with
preliminary observations of analogous connexin changes in other
genodermatosis (unpublished data) and skin cancers (Wingelbus et al,
1992) (unpublished data), these findings indicate that alterations in the
native pattern of connexins, and most strikingly in the expression of
Cx26, are consistent markers of abnormal keratinocyte differentiation.
In vitro studies have shown that Cx26 and Cx43 make gap junction
channels with different biophysical and regulatory properties and are
not able to functionally interact with each other to form heterotypic
channels (White et al, 1995). Hence, one implication of our findings
is that, whereas channels made of Cx43 are sufficient to fulfill the
needs of junctional communication of normal keratinocytes, some
change in these needs requires an additional type of cell-to-cell channel
under pathologic conditions that leads to epidermal hyperplasia. Further
experiments should investigate the reasons why Cx26 is adequately
tailored for these new requirements. An approach to this question is
to determine whether the increased level of this connexin in psoriatic
epidermis is actually paralleled by an increase in the functional coupling
of keratinocytes. Future experiments will determine whether the newly
formed Cx26 channels that add to those normally made by Cx43
upregulate or downregulate the native keratinocyte-to-keratinocyte
communication within the interfollicular epidermis.
Communication via connexins has been implicated in the regulation
of cell growth (Goliger and Paul, 1995; Sawey et al, 1996; Rivas et al,
1997), migration (Pepper et al, 1989; Goliger and Paul, 1995), and
differentiation (Lowenstein and Rose, 1992; Goodenough et al, 1996),
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Figure 4. Distribution of Cx43 in lesional and nonlesional psoriatic skin. (A) Phase-contrast view of the biopsy of a psoriatic patient, comprising a
phenotypically normal region of skin (left side of the photograph) and a region immediately adjacent to a fully developed psoriatic plaque (right side of the
photograph). The latter region is recognizable by the characteristic lengthening of epidermal papillae. (B) Immunolabeling revealed that, in the entire biopsy, Cx43
was distributed throughout all living layers of interfollicular epidermis and predominantly in the spinous and granular layers. (C) Within fully developed psoriatic
plaques, the interfollicular epidermis was markedly thickened and featured long epidermal papillae and regions of parakeratosis. (D) In these plaques, the distribution
of Cx43 was qualitatively similar to that observed in the nonlesional regions of skin, i.e., was higher in the spinous and granular layers than in the basal layer of
keratinocytes and was nil in the keratinized and parakeratotic regions of the squamous layers; however, the levels of Cx43 within psoriatic plaques appeared
increased compared with those observed in nonlesional regions, particularly within the basal and parabasal layers of keratinocytes. Scale bar: 100 µm.
three functions whose alteration significantly contributes to the dysfunc-
tion of psoriatic keratinocytes (Mc Kay and Leigh, 1995). Elucidating
which of these functions, if any, may be affected by altering connexin
channels awaits the result of experiments in which in vitro reconstituted
epidermis, starting from primary human keratinocytes, are combined
with methods for the targeting of specific connexin genes to distinct
keratinocyte subpopulations.
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